Issue 1185, 1974

Bioavailability from pharmaceutical dosage forms

Abstract

The last few years have witnessed a concentration of interest in the effectiveness of pharmaceutical dosage forms. This interest has arisen from a growing awareness that the efficacy of an otherwise acceptable drug can be severely affected by insufficient attention to the manner of its presentation for administration by different manufacturers. This has found expression in the concept of bioavailability.

Strictly, bioavailability is only assessable in terms of availability of the drug substance at the actual site of action. For various reasons, however, direct measurement of bioavailability is frequently not possible in human subjects. Its assessment, therefore, usually rests on the measurement of secondary parameters of which blood levels and urinary excretion data are the most common.

The route of administration adopted for any drug depends on a combination of the clinical requirement, the physicochemical properties of the drug substance, and the extent to which these can be modified by formulation. Within the limitations imposed by such considerations, bioavailability depends principally on the skill of the formulator and his assessment of the physiological parameters that affect the absorption, transport, metabolism and excretion of the drug from the body. Once the product is formulated, standardisation of its production depends on the ability of the production pharmacist and his quality controller to specify and keep check on the parameters necessary to achieve uniformity from one batch to the next.

Physiological factors, which affect blood levels and tissue availability of drug substances, are considered. These include plasma and tissue protein binding, cell binding, lipid deposition and metabolism, and assessment of the interplay between them. The physicochemical properties that affect their availability from oral dosage forms, aerosols and topical preparations are examined with particular reference to factors affecting rates of solution of substances with low water solubility. Crystallinity, polymorphism, particle size, wettability and ease of dissolution are examined from this point of view.

Article information

Article type
Paper

Analyst, 1974,99, 824-837

Bioavailability from pharmaceutical dosage forms

J. B. Stenlake, Analyst, 1974, 99, 824 DOI: 10.1039/AN9749900824

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements